Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor

The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by “on-demand” addition of plerixafor to granulocyte-colony-stimulating factor

(2014) Tamara Girbl et al.   TRANSFUSION

Efficacy of just-in-time plerixafor rescue for Hodgkin's lymphoma patients with poor peripheral blood stem cell mobilization

(2014) Shan Yuan et al.   TRANSFUSION

Hematopoietic SCT in Europe: data and trends in 2011

(2013) J R Passweg et al.   BONE MARROW TRANSPLANTATION

Characterization of peripheral blood stem cell grafts mobilized by granulocyte colony-stimulating factor and plerixafor compared with granulocyte colony-stimulating factor alone

(2013) Beatrice Gaugler et al.   CYTOTHERAPY

Engraftment and outcome after autologous stem cell transplantation in plerixafor-mobilized non-Hodgkin's lymphoma patients

(2013) Ville Varmavuo et al.   TRANSFUSION

Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin’s lymphoma and multiple myeloma: results from the expanded access program

(2012) P Shaughnessy et al.   BONE MARROW TRANSPLANTATION

Efficacy and safety of hematopoietic stem cell remobilization with plerixafor+G-CSF in adult patients with germ cell tumors

(2012) M E Horwitz et al.   BONE MARROW TRANSPLANTATION

Blood graft composition after plerixafor injection in patients with NHL

(2012) Ville Varmavuo et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

European data on stem cell mobilization with plerixafor in patients with nonhematologic diseases: an analysis of the European consortium of stem cell mobilization

(2012) Nina Worel et al.   TRANSFUSION

Blood graft lymphocyte subsets after plerixafor injection in non-Hodgkin's lymphoma patients mobilizing poorly with chemotherapy plus granulocyte-colony-stimulating factor

(2012) Ville Varmavuo et al.   TRANSFUSION

How I treat patients who mobilize hematopoietic stem cells poorly

(2011) L. B. To et al.   BLOOD

European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization

(2011) K Hübel et al.   BONE MARROW TRANSPLANTATION

Preemptive use of plerixafor in difficult-to-mobilize patients: an emerging concept

(2011) Esa Jantunen et al.   TRANSFUSION

Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming

(2011) Erin T. Alexander et al.   TRANSFUSION

Relevance and Clinical Implications of Tumor Cell Mobilization in the Autologous Transplant Setting

(2010) John F. DiPersio et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Plerixafor is effective and safe for stem cell mobilization in heavily pretreated germ cell tumor patients

(2010) S Kobold et al.   BONE MARROW TRANSPLANTATION

A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study

(2010) Stefan Fruehauf et al.   CYTOTHERAPY

Characterization of hematopoietic stem cell subsets from patients with multiple myeloma after mobilization with plerixafor

(2010) Isabel Taubert et al.   CYTOTHERAPY

Plerixafor (AMD3100) and granulocyte colony-stimulating factor (G-CSF) mobilize different CD34+ cell populations based on global gene and microRNA expression signatures

(2009) R. E. Donahue et al.   BLOOD

Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization

(2009) M J Dugan et al.   BONE MARROW TRANSPLANTATION

Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma

(2009) John F. DiPersio et al.   JOURNAL OF CLINICAL ONCOLOGY

A Phase II Study of Plerixafor (AMD3100) plus G-CSF for Autologous Hematopoietic Progenitor Cell Mobilization in Patients with Hodgkin Lymphoma

(2008) Amanda Cashen et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION